Pharmaceutical

Flowcrete Australia manufacturer a wide range of speciality resin floor coatings, which have been installed in the pharmaceutical industry for more than 30 years for clients including GlaxoSmithKline, Pfizer, Becton Dickinson, Roche Pharmaceuticals and AstraZeneca.

With an extensive track record supplying resin flooring to the pharmaceutical industry, Flowcrete is well placed to serve the needs of this clean and sterile sector.

Whether you need floors that are resistant to aggressive chemicals, anti-static systems that dissipate electrical charge or anti-microbial floor finishes, our flooring specification process ensures the right flooring solutions are selected for the different process areas in your environment.

Flowfast, our fast-track floor finish, is ready just two hours after installation and causes minimal disruption to daily operations. It is an excellent example of how we are using research and development to craft systems that are at the forefront of technology in our industry - in order to better serve yours.

Flowcrete's manufacturing process is geared up to comply with the demanding standards the pharmaceutical industry requires - including the relevant BS, GLP, GDP and GMP standards.

Furthermore, the right choice of floor can help to improve productivity and staff morale by creating clean, safe and hygienic environments that are in tune with the unique requirements of the pharmaceutical sector

If you have either a refurbishment or new-build flooring project in the pharmaceutical sector and need some advice from a flooring expert - contact Flowcrete Australia today, we'd be happy to hear from you!